1 – 10 of 31
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Genome-wide meta-analysis of monoclonal gammopathy of undetermined significance (MGUS) identifies risk loci impacting IRF-6
(
- Contribution to journal › Letter
-
Mark
Validation and functional characterization of GWAS-identified variants for chronic lymphocytic leukemia : a CRuCIAL study
(
- Contribution to journal › Letter
- 2021
-
Mark
Germline variants at SOHLH2 influence multiple myeloma risk
(
- Contribution to journal › Article
-
Mark
Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden
(
- Contribution to journal › Article
-
Mark
Characteristics and outcome of acute myeloid leukemia with uncommon retinoic acid receptor-alpha (RARA) fusion variants
(
- Contribution to journal › Letter
-
Mark
Characterization of rare germline variants in familial multiple myeloma
(
- Contribution to journal › Letter
- 2020
-
Mark
International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM)
(
- Contribution to journal › Article
-
Mark
Parental origin of monosomic chromosomes in near-haploid acute lymphoblastic leukemia
(
- Contribution to journal › Letter
-
Mark
The CCND1 c.870G risk allele is enriched in individuals of African ancestry with plasma cell dyscrasias
(
- Contribution to journal › Letter
- 2019
-
Mark
The ALK inhibitor AZD3463 effectively inhibits growth of sorafenib-resistant acute myeloid leukemia
(
- Contribution to journal › Letter